太一斋品牌怎么样 申请店铺

我要投票 太一斋在医疗器械行业中的票数:538 更新时间:2025-12-25
太一斋是哪个国家的品牌?「太一斋」是 周口太一斋医药科技有限公司 旗下著名品牌。该品牌发源于河南周口,由创始人唐晓光在2017.9.29期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力太一斋品牌出海!将品牌入驻外推网,定制太一斋品牌推广信息,可以显著提高太一斋产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

太一斋怎么样

太一斋,地处伏羲故都,老子故里,有“华夏先驱、九州圣迹”的美誉,被中华全国伏羲文化研究会誉为“中华文化发祥的重地”——周口。

太一斋医药致力于挖掘国药精品,国药、保健以及器械等精优产品,弘扬中医文化,立足大健康行业,服务现代人类,集科研开发,生产销售于一体,实施代理,策划,宣传,售后等完善服务的经营方略。

公司尊重知识,重视人才,以人为本,追求科技创新,积极开拓进取,拥有一支高学厉,高素质,高效率的经营管理服务人员,严谨务实,奋发向上。公司随时与国内各大专院校及科研机构保持着密切的协作关系及联络,致力于推出高品质,高疗效,高标准,低价位的优质产品。

公司自创业以来,便以引导,"创新医药"为己任,以优良的产品,优质的服务,优秀的策划,得到全国各地代理商的一致好评,从而使公司在医药界倍受瞩目,颇有赞誉。

在激烈的市场竞争中,太一斋医药以"创新医药"为导向,独树一帜。我们将一如既往地贯彻"造福人类,回报社会"的经营理念,与您携手再创辉煌。

目前,本公司已为全国各地的众多合作伙伴提供了保姆式的便利与服务。同时,为了实现生产力的低成本扩张,太一斋医药密切关注行业发展动态,对市场资源进行进一步的优化整合,然后采取合作共赢、并购重组等方式进一步扩大公司规模,提高企业竞争力。

太一斋坚持"以人为本"的理念,尊重知识、重视人才,倡导员工和公司的共同发展,崇尚开放式的人才选聘模式。正是这种良好的育人环境,为公司吸引了大批优秀人才。目前为止,太一斋拥有大学本科以上学历的员工已达60%以上,形成了一支具有良好专业水平和熟练技能的优秀团队。

在日益激烈的市场竞争面前,太一斋医药摒弃传统的单一营销模式,结合互联网,创立了一套立体化的新型营销模式。坚持优质客户服务,不断引进国内外优势产品及管理模式。取人之长,补己之短。在不断的自我反思和自我完善中提高自己!

在药品研发方面,太一斋坚持以"安全高效"为导向,在千年国药精髓的基础上,加入现代尖端科学技术,选用上乘药材,精致配伍,做良心药,把患者的健康和利益放在首位。努力把自己打造成患者和经销商的坚强后盾,随时随地为其服务!

太一斋医药将继续秉承"造福人类,回报社会"的经营理念,发扬"与时俱进,开拓创新"的创业精神,充分整合运用自身优势及外部资源,全力将太一斋打造成横跨生物医药、现代中成药、化学合成药以及高科技保健品等多项领域的新型医药品牌。

太一斋相信"福报来源于布施",所以,"造福人类,回报社会"将是太一斋人孜孜不倦的追求!

Taiyizhai, located in Fuxi's hometown, Laozi's hometown, has a good reputation of "Chinese pioneer, Kyushu miracle", and is honored as "the birthplace of Chinese culture" by the all China Fuxi Culture Research Association Zhoukou. Taiyizhai medicine is committed to mining the excellent products of national medicine, national medicine, health care and instruments, carrying forward the culture of traditional Chinese medicine, based on the big health industry, serving modern human beings, integrating scientific research and development, production and sales, implementing the business strategy of agent, planning, publicity, after-sales and other perfect services. The company respects knowledge, attaches great importance to talents, people-oriented, pursues scientific and technological innovation, actively develops and advances, has a highly educated, high-quality and efficient management service personnel, rigorous and pragmatic, and strives to make progress. At any time, the company keeps close cooperation and contact with colleges and universities and scientific research institutions in China, and is committed to promoting high-quality, high curative effect, high standard and low price high-quality products. Since its inception, the company has been guided by the "innovative medicine" as its own responsibility, with excellent products, high-quality services, excellent planning, and has been unanimously praised by agents all over the country, so that the company has attracted much attention in the pharmaceutical industry, and has been highly praised. In the fierce market competition, taiyizhai medicine takes "innovative medicine" as the guidance and develops its own school. We will, as always, implement the business philosophy of "benefiting mankind and returning society", and work with you to create brilliant future. At present, our company has provided nanny convenience and service for many partners all over the country. At the same time, in order to realize the low-cost expansion of productivity, taiyizhai pharmaceutical pays close attention to the development trend of the industry, further optimizes and integrates the market resources, and then further expands the company's scale and improves its competitiveness by means of win-win cooperation, merger and acquisition. Taiyizhai adheres to the concept of "people-oriented", respects knowledge, attaches importance to talents, advocates the common development of employees and the company, and advocates an open talent selection mode. It is this kind of good education environment that attracts a large number of excellent talents for the company. So far, more than 60% of taiyizhai's employees with bachelor's degree or above have formed an excellent team with good professional level and skilled skills. In the face of increasingly fierce market competition, taiyizhai medicine abandoned the traditional single marketing mode, combined with the Internet, created a new three-dimensional marketing mode. Adhere to high-quality customer service, and constantly introduce domestic and foreign superior products and management mode. Learn from others and make up for your own shortcomings. In the aspect of drug research and development, taiyizhai adheres to the guidance of "safety and efficiency", on the basis of the essence of Chinese medicine for thousands of years, adds modern cutting-edge science and technology, selects superior medicinal materials, makes delicate compatibility and conscience medicine, and puts the health and interests of patients first. Strive to build itself into a strong backing for patients and dealers, and serve them anytime and anywhere! Taiyizhai medicine will continue to uphold the business philosophy of "benefiting mankind and returning society", carry forward the entrepreneurial spirit of "advancing with the times and developing innovation", fully integrate its own advantages and external resources, and strive to build taiyizhai into a cross biological medicine, modern Chinese patent medicine and chemical synthetic medicine And high-tech health products and other fields of new pharmaceutical brands. Taiyizhai believes that "blessing comes from giving", so "benefiting human beings and repaying society" will be the tireless pursuit of taiyizhai people!

本文链接: https://brand.waitui.com/ef30d5801.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

万朗磁塑:控股股东时乾中拟减持不超3.00%股份

36氪获悉,万朗磁塑公告,控股股东时乾中因自身资金需求,计划自公告披露之日起15个交易日后的3个月内,通过集中竞价和大宗交易方式合计减持不超过256.45万股,占公司总股本的3.00%。其中,集中竞价减持不超过85.48万股,大宗交易减持不超过170.97万股。减持股份来源为首次公开发行前取得的股份。

32分钟前

东阳光:控股子公司东阳光氟增资扩股并引入投资者兴银投资

36氪获悉,东阳光公告,公司控股子公司乳源东阳光氟有限公司拟新增注册资本10,888,889元,由兴银金融资产投资有限公司以7亿元全额认购,公司及子公司乳源东阳光电化厂放弃本次增资的优先认购权。增资完成后,公司直接及间接持有标的公司的股权比例由100%降至96.9828%,仍为控股股东并拥有实际控制权。此次交易旨在增强东阳光氟的资本实力和优化资本结构,符合公司发展战略和全体股东利益。

32分钟前

金埔园林:股东苏高新拟减持不超0.8%公司股份

36氪获悉,金埔园林公告,公司股东苏州新区高新技术产业股份有限公司计划自公告披露之日起三个交易日后的第一个交易日起三个月内,通过集中竞价方式减持公司股份不超过147.88万股,即不超过公司总股本的0.80%。减持价格将根据市场价格确定,减持原因为盘活存量资产、优化产业结构、服务整体发展战略。

32分钟前

新铝时代:持股5%以上股东国同红马拟减持不超2.49%公司股份

36氪获悉,新铝时代公告,公司持股5%以上股东重庆高新创投红马资本管理有限公司-重庆国同红马股权投资基金合伙企业(有限合伙)(简称“国同红马”)计划在预披露公告披露之日起15个交易日后的3个月内(2026年1月20日至2026年4月19日)以集中竞价方式和/或大宗交易方式合计减持股份不超过3,581,647股,占公司总股本的2.49%。

32分钟前

小米17 Ultra机型售价公布:6999元起

36氪获悉,小米正式公布小米17 Ultra售价,其中12GB+512GB售价6999元、16GB+512GB售价7499元、16GB+1TB售价8499元;小米17 Ultra徕卡版共有黑、米白两款配色,其中16GB+512GB售价7999元、16GB+1TB售价8999元。该机型现已开启预售,将于12月27日10时正式开售。

32分钟前

本页详细列出关于太一斋的品牌信息,含品牌所属公司介绍,太一斋所处行业的品牌地位及优势。
咨询